tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
US Market

Apellis Pharmaceuticals (APLS) Income Statement

Compare
883 Followers

Apellis Pharmaceuticals Income Statement

Last quarter (Q4 2024), Apellis Pharmaceuticals's total revenue was $212.53M, an increase of 45.19% from the same quarter last year. In Q4, Apellis Pharmaceuticals's net income was $-36.35M. See Apellis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 709.95M$ 396.59M$ 75.42M$ 66.56M$ 250.65M
Gross Profit
$ 592.23M$ 338.08M$ 69.79M$ 61.36M$ 225.60M
Operating Expenses
$ 828.62M$ 855.20M$ 664.40M$ 597.64M$ 439.32M
Depreciation and Amortization
$ 1.80M$ 1.70M$ 1.49M$ 1.49M$ 859.00K
EBITDA
$ -236.39M$ -495.21M$ -617.39M$ -731.27M$ -312.23M
Operating Income
$ -236.39M$ -517.12M$ -594.61M$ -536.28M$ -213.73M
Other Income/Expenses
$ 39.68M$ -9.38M$ -56.89M$ -209.72M$ -129.30M
Pretax Income
$ -196.72M$ -526.50M$ -651.50M$ -746.00M$ -343.03M
Net Income
$ -197.88M$ -528.63M$ -652.17M$ -746.35M$ -344.87M
Per Share Metrics
Basic EPS
$ -1.60$ -4.45$ -6.15$ -8.84$ -4.59
Diluted EPS
$ -1.60$ -4.45$ -6.15$ -8.84$ -4.59
Weighted Average Shares Outstanding
123.90M 118.68M 106.11M 84.42M 75.16M
Weighted Average Shares Outstanding (Diluted)
123.90M 118.68M 106.11M 84.42M 75.16M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis